Evolus (EOLS) Q2 2025 Earnings Call Transcript
Source: Motley Fool
2026-05-04 16:34:49 ET
Image source: The Motley Fool.
Tuesday, August 5, 2025 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
-4.45% G/L:
$5.47 Last:
451,557 Volume:
$5.522 Open:
EOLS Latest News
July 09, 2026 08:16:00 am
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
July 08, 2026 09:00:00 am
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
May 26, 2026 11:18:51 am
A New Copper-Gold Porphyry Target in Southern Ecuador Lands on Salazar Resources' Cornerstone Project Map
May 22, 2026 10:31:00 am
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
